Clinical trial
Effect of Dexmedetomidine Combined With Ropivacaine Transverse Abdominal Plane Block (TAP) on Opioid Dosage After Cesarean Section Under Multimodal Analgesia
NCT05700045 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Dexmedetomidine Combined With Ropivacaine Transverse Abdominal Plane Block (TAP) on Opioid Dosage After Cesarean Section Under Multimodal Analgesia
- Lead sponsor
- Xijing Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2023
- Completion date
- September 30, 2023
- Enrollment
- 90 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cesarean section, multimodal analgesia